Figure 7 | Scientific Reports

Figure 7

From: The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study

Figure 7

Immunocytochemical staining and propranolol plus docetaxel effectiveness in SFT primary cell models. (A) β-AR expression in SFT cells. Image scale bar, 100 µm. (B) SFT cells were incubated with docetaxel alone or in combination with propranolol for 72 h. The inhibition of cell proliferation, shown in the histogram, is the mean median of three experiments (mean ± SD, ***p < 0.001; *p < 0.05; where p values of single drugs were calculated with respect to Ctrl, while the p value of combination was calculated with respect to single drugs).

Back to article page